IPMPC 2020 Year in Review Cover Page.JPG

EFPIA-IPMPC Comments on EDPB Recommendations

Importance of Transatlantic Data Flows to Healthcare Innovation and Delivery

EFPIA-IPMPC Submission to EDPB Regarding Controller-Processor Guidelines

Personal Data’s Role in Advancing Health Care Innovation

IPMPC Submission on EMA Discussion Paper for Medicines Developers, Data Providers, Research-Performing and Research-Supporting Infrastructures on GDPR and Secondary Use of Data for Medicines and Public Health Purposes

IPMPC White Paper: The Evolving Ethical and Legal Framework for the Use of AI in the Pharmaceutical and Medical Device Industries

IPMPC Comments on EDPS Preliminary Opinion on Scientific Research Purposes

IPMPC Comments on Version 3 of Revised CCPA Proposed Regulations

IPMPC Comments on Revised CCPA Regulations

IPMPC Comments to the California Attorney General re Proposed CCPA Regulations

IPMPC White Paper on the Role of Personal Data in Healthcare

IPMPC Principles for US Privacy Legislation

Over the last century, medical science has transformed human health and dramatically increased life expectancy. The life saving treatments available today were made possible by an environment that fostered medical research. The scientific process used in medical research relies on the ability to effectively collect, analyze and reanalyze patient health information. Pharmaceutical companies collect patient health information created in controlled research settings (e.g., clinical trials to investigate an experimental drug), as well as real world patient health data.